Tissue Banking Market
Report ID: SQMIG35J2128
Tissue Banking Market Size
SkyQuest Technology's Tissue banking market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Tissue Banking Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.
Tissue Banking Market Insights
Global Tissue Banking Market size was valued at USD 4.3 Billion in 2023 poised to grow from USD 4.53 Billion in 2024 to USD 6.84 Billion by 2032, growing at a CAGR of 5.3% in the forecast period (2025-2032).
The global rise in chronic diseases such as cardiovascular disorders, diabetes, and cancer, along with increasing incidences of trauma and severe burns, has significantly amplified the number of transplant surgeries being performed each year. This surge in surgical interventions leads to a heightened need for human tissues—such as heart valves, corneas, skin grafts, and bone segments—which are crucial for successful reconstructive and therapeutic procedures. In response, healthcare institutions and governments are investing in expanding tissue banking infrastructure to meet the growing demand. This cause-effect relationship directly drives market growth by ensuring a continuous supply of safe and preserved tissues.
Breakthroughs in tissue preservation methods, such as cryopreservation, lyophilization, and vitrification, have significantly enhanced the viability, functionality, and long-term storage of donated tissues are some of the key trends driving the global tissue banking sector. These technologies reduce the risk of contamination and degradation, thereby increasing the shelf life and safety of grafts. As a result, healthcare providers are more confident in utilizing banked tissues for complex surgeries, and patients benefit from improved outcomes. Moreover, these innovations have enabled the storage of a broader range of tissues, including more delicate types like amniotic membranes and cartilage, expanding the application scope of tissue banks and supporting market expansion globally.
How do AI Advancements Reduce Human Error in Tissue Banking Workflows?
Artificial intelligence (AI) is significantly transforming the global tissue banking market by enhancing operational efficiency, predictive analytics, and regulatory compliance. AI-powered tissue banking software automates routine tasks such as sample tracking, labeling, and documentation, thereby reducing human error and improving workflow efficiency. Moreover, AI algorithms analyze complex datasets—including donor information, tissue characteristics, and environmental conditions—to predict tissue viability and transplantation success rates. This predictive capability assists clinicians in selecting the most suitable tissues for patients, leading to improved outcomes. Additionally, AI systems can interpret vast regulatory guidelines and historical data to ensure compliance, minimizing errors and reducing the risk of violations. Collectively, these advancements are propelling the growth and modernization of the tissue banking sector.
In January 2025, Dublin-based medical technology firm Deciphex secured €31 million in Series C funding to enhance its AI-driven diagnostic platforms, Diagnexia and Patholytix. These platforms utilize artificial intelligence to assist pathologists in diagnosing diseases more efficiently, addressing the global shortage of pathologists.
Tissue Banking Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
